Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Uber Technologies Inc — how do they compare? ARK Genomic Revolution ETF trades at $41, while Uber Technologies Inc trades at $74.66 (market cap $151.73B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Uber Technologies Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | UBER | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $100.10 |
52-Week Low | $23.09 | $68.61 |
Market Cap | — | $151.73B |
Enterprise Value | — | $158.06B |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Uber trades at $74.54, up 0.26% today, with a bullish technical signal from moving averages and strong analyst consensus. Revenue grew to $52.02 billion in 2025, with net income of $10.05 billion, though margins are expected to moderate. Recent news highlights expansion into robotaxis in Europe and cost-cutting measures, including HR layoffs and AI spending caps.
The outlook remains positive with an 81.67% buy rating from analysts and a $109.25 price target, but risks include competitive pressures in key markets like India, regulatory scrutiny, and projected negative net cash flow in 2026. Earnings volatility, as seen in Q4 2025's miss, adds uncertainty.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides aerial ride-sharing. Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 110 million users that order rides or foods at least once a month. Approximately 76% of its gross revenue comes from ride-sharing and 22% from food delivery.
Read more on UBER →